Worth Venture Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$1.3M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$605K |
| 3 |
NetEase
NTES
|
+$589K |
| 4 |
Canadian Pacific Kansas City
CP
|
+$531K |
| 5 |
OTIC
Otonomy, Inc.
OTIC
|
+$432K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$1.9M |
| 2 |
VGR
Vector Group Ltd.
VGR
|
+$774K |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$690K |
| 4 |
Silicom
SILC
|
+$367K |
| 5 |
Mastercard
MA
|
+$361K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.64% |
| 2 | Consumer Discretionary | 4.92% |
| 3 | Communication Services | 4.55% |
| 4 | Healthcare | 3.41% |
| 5 | Real Estate | 2.55% |
Similar funds
Worth Venture Partners's Q3 2017 Portfolio in Review
As of Q3 2017, Worth Venture Partners held 157 positions worth $115M, down 0.58% from $116M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Worth Venture Partners withdrew a net $15.8M in Q3 2017, closing 26 positions and reducing 31 holdings. Its most notable exit was Arista Networks, an estimated $1.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 8% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, Worth Venture Partners opened a new position in PTC Therapeutics worth $1.32M.
- Worth Venture Partners's largest Q3 2017 buy was PTC Therapeutics: 66,196 shares worth $1.32M.
- Worth Venture Partners added most to NetEase in Q3 2017, an estimated $589K increase.
- Worth Venture Partners's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $690K.
- Worth Venture Partners fully exited Arista Networks in Q3 2017, selling an estimated $1.9M.
- Worth Venture Partners's ten largest holdings make up 55% of its $115M portfolio in Q3 2017.
- Worth Venture Partners opened 40 new positions and closed 26 in Q3 2017.
- Worth Venture Partners's portfolio value fell 0.58% quarter-over-quarter to $115M.
Based on Worth Venture Partners's 13F filing for Q3 2017, filed 7 Nov 2017.